BioRestorative Therapies (NASDAQ:BRTX) Announces Quarterly Earnings Results

BioRestorative Therapies (NASDAQ:BRTX) released its quarterly earnings data on Thursday. The company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.07, Zacks reports. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%. The business had revenue of $0.50 million during the quarter, compared to the consensus estimate of $0.48 million.

BioRestorative Therapies Stock Performance

BRTX stock opened at $1.81 on Friday. The firm has a fifty day moving average price of $1.97 and a 200 day moving average price of $1.72. BioRestorative Therapies has a fifty-two week low of $1.03 and a fifty-two week high of $2.55. The firm has a market cap of $12.53 million, a PE ratio of -1.18 and a beta of 64.37.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.